Medical Education
January 21, 2023

December 2022: Meducom provides local regulatory dossier support

In January 2022, the EU formally approved a new indication for an oncological drug in…
Read More
Medical Communication
January 21, 2023

July 2022: Meducom supports development of information cards for patients

When patients are diagnosed with cancer, they may be overwhelmed with questions. What is going…
Read More
January 21, 2023

March 2022: Meducom supports important publication on reduced cardiotoxicity after switch to another chemotherapy

Fluoropyrimidine chemotherapy is widely used in many solid tumours, but is associated with cardiotoxicity. In…
Read More
January 21, 2023

January 2022: EMA approves dossier for new indication for drug in metastatic colorectal cancer

During most of 2021, Meducom worked hard to support a client and clinical experts in…
Read More
April 16, 2021

March 2021: Meducom provides publication support of important Finnish colorectal cancer study

Colorectal cancer (CRC) is the third most common cancer worldwide with 1.8 million new cases…
Read More
Medical Communication
April 13, 2021

November 2020: Expert medical support for regulatory affairs and dossiers

Tailored expert medical communication is becoming more and more important. With our expertise, Meducom increasingly…
Read More
Featured
July 6, 2020

March 2020: Meducom celebrates its 15th anniversary!

Following 10 years of academic medical research combined with many years of experience in the…
Read More
Medical Education
June 18, 2020

November 2019: Meducom wins competitive pitch

At the end of 2019, Meducom was invited by an international biotechnology company specialised in…
Read More